Revvity (RVTY) Liabilities and Shareholders Equity (2010 - 2026)
Revvity's (RVTY) quarterly Liabilities and Shareholders Equity came in at $12.0 billion in Q2 2026, down 2.95% YoY from $12.4 billion in Q2 2025, and down 1.41% on a QoQ basis from $12.2 billion in Q4 2025.
Revvity (RVTY) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Revvity (RVTY) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $12.0 billion in Q2 2026.
- Quarterly Liabilities and Shareholders Equity fell 2.95% year-over-year to $12.0 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $48.7 billion (down 4.48% YoY) and the FY2025 annual result came in at $12.2 billion, down 1.81% from the prior year.
- Liabilities and Shareholders Equity slipped to $12.0 billion in Q2 2026, from $12.2 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $15.0 billion in Q1 2022 to a low of $12.0 billion in Q2 2026.
- A 5-year average of $13.4 billion and a median of $13.4 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 88.44% — and 2024, when it fell 8.64%.
- Tracing RVTY's Liabilities and Shareholders Equity over 5 years: stood at $13.8 billion in 2022, then fell by 1.87% to $13.6 billion in 2023, then fell by 8.64% to $12.4 billion in 2024, then slipped by 1.81% to $12.2 billion in 2025, then declined by 1.41% to $12.0 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $12.0 billion (Q2 2026), $12.2 billion (Q4 2025), and $12.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 113.17 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 92.37 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 2.66 Bn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 13.07 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 29.88 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 3.44 Bn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.65 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.67 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 18.53 Bn |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn | 12.05 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | 12.05 Bn |
| Apr 5, 2026 | 12.00 Bn |
| Dec 28, 2025 | 12.17 Bn |
| Sep 28, 2025 | 12.14 Bn |
| Jun 29, 2025 | 12.36 Bn |
| Mar 30, 2025 | 12.36 Bn |
| Dec 29, 2024 | 12.39 Bn |
| Sep 29, 2024 | 12.77 Bn |
| Jun 30, 2024 | 13.42 Bn |
| Mar 31, 2024 | 13.43 Bn |
| Dec 31, 2023 | 13.56 Bn |
| Oct 1, 2023 | 13.42 Bn |
| Jul 2, 2023 | 14.22 Bn |
| Apr 2, 2023 | 14.64 Bn |
| Jan 1, 2023 | 14.13 Bn |
| Oct 2, 2022 | 13.82 Bn |
| Jul 3, 2022 | 14.19 Bn |
| Apr 3, 2022 | 14.85 Bn |
| Jan 2, 2022 | 15.00 Bn |
| Oct 3, 2021 | 14.90 Bn |